Meireles Pedro Antunes, Bessa Filipe, Gaspar Pedro, Parreira Inês, Silva Virgílio Dias, Mota Catarina, Alvoeiro Lourdes
Serviço de Medicina 2, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Serviço de Oncologia Médica, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
Eur J Case Rep Intern Med. 2020 May 13;7(6):001710. doi: 10.12890/2020_001710. eCollection 2020.
Coronavirus disease 2019 (COVID-19) is a multisystemic condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with manifestations ranging from mild upper respiratory symptoms to cytokine storm causing acute respiratory distress syndrome. Pancreatic exocrine tissue and endocrine islets both express angiotensin-converting enzyme 2 (ACE2), the proven receptor for SARS-CoV-2 cell internalization. An increase in pancreatic enzymes has been increasingly recognized in patients with COVID-19, but little is known about the real prevalence of acute pancreatitis in this population. We report a case of acute acalculous pancreatitis in a COVID-19 patient.
Acute pancreatitis may be a manifestation of SARS-CoV-2 infection.Future studies must address the real impact of pancreatic involvement in COVID-19 patients.
2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的多系统疾病,其表现从轻度上呼吸道症状到导致急性呼吸窘迫综合征的细胞因子风暴不等。胰腺外分泌组织和内分泌胰岛均表达血管紧张素转换酶2(ACE2),这是已证实的SARS-CoV-2细胞内化受体。COVID-19患者中胰腺酶升高越来越受到认可,但该人群中急性胰腺炎的实际患病率知之甚少。我们报告一例COVID-19患者的急性非结石性胰腺炎病例。
急性胰腺炎可能是SARS-CoV-2感染的一种表现。未来的研究必须关注胰腺受累对COVID-19患者的实际影响。